论文信息 - Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer. - 字舞流文

Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer.

R. Valenta | M. Preusser | Dominic Fong | M. Mitterer | P. Gattinger | M. Mair | J. M. Berger